Pharmaceuticals & Medical Research Sector Actividad de insiders

Sigue las compras y ventas de insiders en acciones de Healthcare. Descubre qué ejecutivos compran, la actividad neta de insiders y el % del capital flotante negociado en 2,084 empresas.
La información que se muestra en esta pantalla tiene fines meramente informativos y no constituye asesoramiento financiero. No recomendamos ninguna inversión específica basándonos en estos criterios.
Empresas
Datos
Suscríbase para acceder a todos los datos.
Compañía Grupo industrial Capitalización de mercado ($) # Compras netas de insiders Valor neto de la compra ($) % de flotación comprada % de acciones en manos de insiders
Pharmaceuticals Mega (1.0tn) 0 No hay actividad — 0–15%
Pharmaceuticals Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (488.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (372.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (313.6bn) 0 No hay actividad — —
CH Novartis AG (NOVN)
Pharmaceuticals Mega (275.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Mega (221.8bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Mega (201.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (189.3bn) 0 No hay actividad — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (162.6bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (130.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (125.5bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (104.9bn) 0 No hay actividad — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (92.8bn) 11–20 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (84.8bn) 0 No hay actividad — 0–15%
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (78.6bn) 0 No hay actividad — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 No hay actividad — —
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 No hay actividad — 0–15%
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (59.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (57.0bn) 0 No hay actividad — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 0 No hay actividad — —
Pharmaceuticals Large (51.4bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (44.1bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (43.8bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (43.5bn) 1–5 $100K–$1M 0–15% 15–50%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 No hay actividad — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals Large (39.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals Large (39.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (33.8bn) 0 No hay actividad — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (33.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (32.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (32.0bn) 0 No hay actividad — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (28.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (27.6bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals Large (26.7bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals Large (26.6bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (26.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Incyte Corp (INCY)
Pharmaceuticals Large (25.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (23.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (22.3bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 No hay actividad — 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals Large (20.1bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (19.4bn) 0 No hay actividad — 50%+
Biotechnology & Medical Research Large (16.8bn) -6–10 -$100M+ -0–15% 15–50%
Pharmaceuticals Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 No hay actividad — 15–50%
Biotechnology & Medical Research Large (14.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (14.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (14.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (14.2bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (14.0bn) 0 No hay actividad — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Biotechnology & Medical Research Large (13.9bn) -6–10 -$10M–$100M -0–15% 15–50%
Biotechnology & Medical Research Large (13.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (13.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (13.2bn) 0 No hay actividad — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (13.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (12.9bn) 0 No hay actividad — 50%+
IE ICON PLC (ICLR)
Biotechnology & Medical Research Large (12.9bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (12.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (12.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (12.5bn) 0 No hay actividad — 50%+
Pharmaceuticals Large (12.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (12.4bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals Large (12.1bn) 0 No hay actividad — 0–15%
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (12.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (11.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (11.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (11.2bn) 0 No hay actividad — 0–15%
Pharmaceuticals Large (11.2bn) 1–5 $1M–$10M 0–15% 0–15%
Biotechnology & Medical Research Large (11.0bn) 0 No hay actividad — 15–50%
Biotechnology & Medical Research Large (10.9bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 No hay actividad — 50%+
Pharmaceuticals Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.3bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (10.2bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (10.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (9.9bn) 0 No hay actividad — 50%+
Biotechnology & Medical Research Mid (9.8bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 No hay actividad — 15–50%
Biotechnology & Medical Research Mid (9.1bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (9.0bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (9.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 No hay actividad — 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (8.6bn) -1–5 -$10M–$100M -0–15% 0–15%
US Vaxcyte Inc (PCVX)
Biotechnology & Medical Research Mid (8.4bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (8.4bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Abivax SA (ABVX)
Biotechnology & Medical Research Mid (8.3bn) 0 No hay actividad — 0–15%
Biotechnology & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%